Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can schools and doctors together boost HPV shots in teens?

NCT ID NCT04945655

Vaccine Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether combining school education, doctor training, and offering the vaccine at school can increase HPV vaccination among French adolescents aged 11 to 14. Over 30,000 teens from 90 towns took part. The goal was to see if these efforts make more teens get the HPV vaccine, which helps prevent certain cancers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30,739 people

The number who actually took part.

Started

Nov 2021

Finished

Apr 2023

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Adolescents and parents' education and motivation at school (component 1 -- arms 1-4) and "KABP-6C" survey among adolescents and parents (arms 1-6) Inclusion Criteria: * Adolescents (school years 9-10), and parents of adolescents (school years 7-10) attending secondary schools in the participating municipalities. Exclusion Criteria: * / General practitioners' training (component 2) and "KABP-6C" survey among general practitioners (arms 1, 2 and 5) Inclusion Criteria: * General practitioners' practicing in the participating municipalities. Exclusion Criteria: * Exclusive particular type of practice. * Planning to retire or move their practice within the study period. * No internet access. Access to vaccination at school (component 3 -- arms 1 and 3) Inclusion Criteria: * Adolescents (school years 7-10) attending secondary schools in the participating municipalities, aged 11-14 years (with a possible catch-up for those aged 15-19 years according to the French recommendations). Exclusion Criteria: * Having initiated HPV vaccination. * No written consent from parents/caregivers for vaccination. * Contraindication to HPV vaccination.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV vaccine acceptability are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

human papilloma virus infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV vaccine acceptability

Contacts and locations

Locations

  • Secondary schools and GPs' practices of the participating municipalities

    Multiple Locations, France